OQS Stock Chart & Stats
€2.08
-€0.02(-1.11%)
At close: 4:00 PM EST
€2.08
-€0.02(-1.11%)
Day’s Range― - ―
52-Week Range€1.76 - €2.58
Previous CloseN/A
Volume0.00
Average Volume (3M)41.00
Market Cap
€553.71M
Enterprise Value€1.07K
Total Cash (Recent Filing)€159.83M
Total Debt (Recent Filing)€9.88M
Price to Earnings (P/E)46.2
Beta0.18
Next Earnings
Aug 24, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding298,718,260
10 Day Avg. Volume111
30 Day Avg. Volume41
Financial Highlights & Ratios
PEG Ratio0.95
Price to Book (P/B)5.85
Price to Sales (P/S)6.18
P/FCF Ratio34.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€2.15Price Target Upside3.27% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.04
Revenue Forecast (FY)€145.31M
Bulls Say, Bears Say
Bulls Say
High Gross And Net MarginsSustained high gross margins (≈78%) and improving net margin (~10%) reflect durable pricing power and a premium consumables business. High margins on consumables underpin cash generation and reinvestment capacity, providing resilience to cost shocks and supporting long-term profitability.
Recurring Revenue From Growing Installed BaseA growing installed base (38k devices, +6% YoY) and recurring revenue growth (~9%) create annuity-like cash flows. Consumables and service pull-through drive predictable revenue per device, improving visibility and margin stability as install penetration and upgrade activity expand over time.
Low Leverage And Strong LiquidityA debt-free position and sizable cash balance (~$160M) plus minimal leverage provide financial flexibility to fund CORIS commercialization, working capital and targeted buybacks without straining the balance sheet. This reduces refinancing risk and supports durable investment capacity.
Bears Say
Gross Margin ModerationMargin erosion from tariffs, higher airfreight and adverse mix is structural risk if trade costs or ASP mix persist. Even modest compression from these factors reduces the margin cushion on consumables and capital sales, forcing pricing actions or efficiency gains to maintain profitability.
FX Sensitivity To GuidanceExplicit sensitivity to AUD/USD shifts introduces recurring reporting volatility and revenue risk despite hedging. Currency swings can materially affect reported top-line and margins, complicating forecasting and potentially reducing cash flows if rates move unfavorably over the medium term.
CORIS Commercialization Increases Near-term Cash And OpExCommercializing CORIS requires incremental OpEx, inventory build and controlled market releases ahead of revenue. This creates execution and cash-conversion risk: higher investment and inventory elevate near-term cash usage and pressure margins until commercial ramp and adoption materialize in FY27 and beyond.
Nanosonics Limited News
OQS FAQ
What was Nanosonics Limited’s price range in the past 12 months?
Nanosonics Limited lowest stock price was €1.76 and its highest was €2.58 in the past 12 months.
What is Nanosonics Limited’s market cap?
Nanosonics Limited’s market cap is €553.71M.
When is Nanosonics Limited’s upcoming earnings report date?
Nanosonics Limited’s upcoming earnings report date is Aug 24, 2026 which is in 25 days.
How were Nanosonics Limited’s earnings last quarter?
Nanosonics Limited released its earnings results on Feb 23, 2026. The company reported €0.019 earnings per share for the quarter, the consensus estimate of €0.019 by €0.
Is Nanosonics Limited overvalued?
According to Wall Street analysts Nanosonics Limited’s price is currently Undervalued.
Does Nanosonics Limited pay dividends?
Nanosonics Limited does not currently pay dividends.
What is Nanosonics Limited’s EPS estimate?
Nanosonics Limited’s EPS estimate is 0.01.
How many shares outstanding does Nanosonics Limited have?
Nanosonics Limited has 298,718,260 shares outstanding.
What happened to Nanosonics Limited’s price movement after its last earnings report?
Nanosonics Limited reported an EPS of €0.019 in its last earnings report, expectations of €0.019. Following the earnings report the stock price went down -15.487%.
Which hedge fund is a major shareholder of Nanosonics Limited?
Currently, no hedge funds are holding shares in DE:OQS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nanosonics Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€2.15 (3.27% Upside)
€2.15 (3.27% Upside)
Blogger Sentiment
Bullish
DE:OQS Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
71.59%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
17.94%
Trailing 12-Months
Company Description
Nanosonics Limited
Nanosonics Limited, along with its subsidiaries, functions as a global infection prevention enterprise with operations in Australia and beyond. The company focuses on the production and distribution of its trophon ultrasound probe disinfection system, including all related supplies and accessories. Additionally, it dedicates resources to the exploration, development, and market launch of innovative infection control, decontamination products, and their associated technologies. Key offerings from Nanosonics include trophon2, an advanced device for high-level disinfection of ultrasound probes; trophon EPR, a low-temperature, high-level disinfection method specifically for intra-cavity ultrasound probes; and Nanosonics AuditPro, a comprehensive solution for managing compliance with infection control workflows. Established in 2000, Nanosonics Limited is headquartered in Macquarie Park, Australia.
OQS Stock 12 Month Forecast
Average Price Target
€2.15
▲(3.27% Upside)
Technical Analysis
Ansell
―
Polynovo
―
Paragon Care Limited
―
Trajan Group Holdings Ltd
―
CleanSpace Holdings Ltd.
―








